Evidence map›Paper›PMID 26622461›Full record

ArticleExperimental and therapeutic medicine2015

Zhiqiang Li, Junbo Zhang, K E Zhang, Qiang Fu, Zhen Wang, Tiansen Li, Hui Zhang, Fei Guo, Chuangfu Chen

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Cell insight · 2024
    Review
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Zhiqiang LiCollege of Animal Science and Technology, Shihezi University, Shihezi, Xinjiang 832000, P.R. China.
Junbo ZhangCollege of Animal Science and Technology, Shihezi University, Shihezi, Xinjiang 832000, P.R. China.
K E ZhangCollege of Animal Science and Technology, Shihezi University, Shihezi, Xinjiang 832000, P.R. China.
Qiang FuCollege of Animal Science and Technology, Shihezi University, Shihezi, Xinjiang 832000, P.R. China.
Zhen WangCollege of Animal Science and Technology, Shihezi University, Shihezi, Xinjiang 832000, P.R. China.
Tiansen LiCollege of Animal Science and Technology, Shihezi University, Shihezi, Xinjiang 832000, P.R. China.
Hui ZhangCollege of Animal Science and Technology, Shihezi University, Shihezi, Xinjiang 832000, P.R. China.
Fei GuoCollege of Medicine, Shihezi University, Shihezi, Xinjiang 832000, P.R. China.
Chuangfu ChenCollege of Animal Science and Technology, Shihezi University, Shihezi, Xinjiang 832000, P.R. China.
Shihezi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brucellosis is a zoonotic disease that poses a serious threat to public health and safety. Although the live attenuated vaccines targeting brucellosis, such as M5-90, are effective, there are a number of drawbacks to their use. For example, the vaccines are unable to differentiate between the natural and vaccinated forms of the infection, and these vaccines have also been shown to cause abortion in pregnant animals. Therefore, a safer and more potent vaccine is required. In the present study, a

Indexed as

16MΔTcfSRBrucellavaccine

Identifiers

PMID26622461
PMCPMC4533132
OpenAlexW2107896108

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.